Labiana Health, S.A. (BME:LAB)
4.820
+0.020 (0.42%)
At close: Nov 16, 2026
Labiana Health Market Cap
Labiana Health has a market cap or net worth of €40 million as of November 16, 2026. It is the 30,846th most valuable company in the world and the 188th biggest in Spain. Its market cap has increased by 29.96% in one year.
Market Cap
40.00M
Enterprise Value
69.79M
Revenue
76.44M
Global Rank
Country Rank
#188 Spain
PE Ratio
13.19
ChartMarket Cap Chart
Since June 24, 2022, Labiana Health's market cap has increased from 33.22M to 40.00M, an increase of 20.42%. That is a compound annual growth rate of 4.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 40.00M | 18.15% |
| Dec 31, 2025 | 33.86M | 62.46% |
| Dec 31, 2024 | 20.84M | 134.14% |
| Dec 29, 2023 | 8.90M | -63.32% |
| Dec 30, 2022 | 24.26M | -26.96% |
| Jun 24, 2022 | 33.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.96B |
| Laboratorios Farmaceuticos Rovi | 3.54B |
| Almirall | 2.33B |
| Faes Farma | 1.58B |
| Laboratorio Reig Jofre | 213.40M |
| Prim, S.A. | 211.75M |
| Atrys Health | 202.67M |
| Oryzon Genomics | 192.28M |